Literature DB >> 22345301

MicroRNAs: novel biomarkers for lung cancer diagnosis, prediction and treatment.

Qiming Wang1, Sheng Wang, Huijuan Wang, Peng Li, Zhiyong Ma.   

Abstract

MicroRNAs (miRNAs) are short non-protein-coding RNAs that post-transcriptionally regulate mRNA expression. A large body of evidence has identified important roles for these regulators in cell proliferation, differentiation, apoptosis and metabolism, as well as activation of oncogenic and antioncogenic signals. Aberrant expression of miRNAs has been found in most human malignancies and is strongly associated with tumorigenesis, prediction, diagnosis, progress, treatment and prognosis. Thus, miRNAs may become an intriguing and promising therapeutic target for many diseases, including cancer. In addition, research into miRNAs may provide insight into the mechanisms underlying tumor occurrence, progression and metastasis. This review summarizes the current knowledge of miRNAs, their roles in lung cancer and avenues for future research.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22345301     DOI: 10.1258/ebm.2011.011192

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  14 in total

1.  Circulating tumor-derived biomarkers in lung cancer.

Authors:  Aline Taenzer; Catherine Alix-Panabières; Harriet Wikman; Klaus Pantel
Journal:  J Thorac Dis       Date:  2012-10       Impact factor: 2.895

2.  Increased micro-RNA 17, 21, and 192 gene expressions improve early diagnosis in non-small cell lung cancer.

Authors:  Zhan Qi; Da-Yun Yang; Jun Cao
Journal:  Med Oncol       Date:  2014-08-22       Impact factor: 3.064

3.  MicroRNA-100 is a potential molecular marker of non-small cell lung cancer and functions as a tumor suppressor by targeting polo-like kinase 1.

Authors:  Jing Liu; Kai-Hua Lu; Zhi-Li Liu; Ming Sun; Wei De; Zhao-Xia Wang
Journal:  BMC Cancer       Date:  2012-11-14       Impact factor: 4.430

4.  MicroRNA 192 regulates chemo-resistance of lung adenocarcinoma for gemcitabine and cisplatin combined therapy by targeting Bcl-2.

Authors:  Jun Cao; Yang He; Hong-Qiang Liu; Sai-Bo Wang; Bao-Cheng Zhao; Ying-Sheng Cheng
Journal:  Int J Clin Exp Med       Date:  2015-08-15

5.  Epigenetic Therapy in Lung Cancer - Role of microRNAs.

Authors:  Sacha I Rothschild
Journal:  Front Oncol       Date:  2013-06-19       Impact factor: 6.244

6.  MicroRNA-650 was a prognostic factor in human lung adenocarcinoma and confers the docetaxel chemoresistance of lung adenocarcinoma cells via regulating Bcl-2/Bax expression.

Authors:  Jia-Yuan Huang; Shi-Yun Cui; Yi-Tian Chen; Hai-Zhu Song; Gui-Chun Huang; Bing Feng; Ming Sun; Wei De; Rui Wang; Long-Bang Chen
Journal:  PLoS One       Date:  2013-08-21       Impact factor: 3.240

7.  MicroRNA-361-3p suppresses tumor cell proliferation and metastasis by directly targeting SH2B1 in NSCLC.

Authors:  Wei Chen; Jun Wang; Sulai Liu; Shaoqiang Wang; Yuanda Cheng; Wolong Zhou; Chaojun Duan; Chunfang Zhang
Journal:  J Exp Clin Cancer Res       Date:  2016-05-10

8.  High copy number variation of cancer-related microRNA genes and frequent amplification of DICER1 and DROSHA in lung cancer.

Authors:  Karol Czubak; Marzena Anna Lewandowska; Katarzyna Klonowska; Krzysztof Roszkowski; Janusz Kowalewski; Marek Figlerowicz; Piotr Kozlowski
Journal:  Oncotarget       Date:  2015-09-15

9.  Lung cancer biomarkers: State of the art.

Authors:  Sangeetha Subramaniam; Ram Krishna Thakur; Vinod Kumar Yadav; Ranjan Nanda; Shantanu Chowdhury; Anurag Agrawal
Journal:  J Carcinog       Date:  2013-02-28

Review 10.  Modulation of cancer traits by tumor suppressor microRNAs.

Authors:  Ioannis Grammatikakis; Myriam Gorospe; Kotb Abdelmohsen
Journal:  Int J Mol Sci       Date:  2013-01-16       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.